Your browser doesn't support javascript.
loading
Efficacy and Safety of Chinese Herbal Medicine Compared With Losartan for Mild Essential Hypertension: A Randomized, Multicenter, Double-Blind, Noninferiority Trial.
Lai, Xinxing; Dong, Zhenyu; Wu, Shengxian; Zhou, Xiaohua; Zhang, Genming; Xiong, Shangquan; Wu, Wei; Cao, Rui; Wang, Xiaolong; Hua, Qi; Du, Jinhang; Fan, Jinying; Mao, Jingyuan; Jiang, Weimin; Yuan, Huishu; Chen, Yushan; Xu, Yong; Li, Zhanquan; Zhang, Jun; Dong, Guiying; Zhen, Hui; Ding, Ru; Wu, Zonggui; Gao, Ying.
Afiliação
  • Lai X; Institute for Brain Disorders, Beijing University of Chinese Medicine, Beijing, China (X.L., Y.G.).
  • Dong Z; Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China (X.L., S.W., G.Z., Y.G.).
  • Wu S; Institute for TCM-X, MOE Key Laboratory of Bioinformatics/Bioinformatics Division, BNRIST, Department of Automation, Tsinghua University, Beijing, China. (X.L.).
  • Zhou X; Department of Traditional Chinese Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China (Z.D., R.C.).
  • Zhang G; Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China (X.L., S.W., G.Z., Y.G.).
  • Xiong S; Department of Biostatistics, Beijing International Center for Mathematical Research, Peking University, China (X.Z.).
  • Wu W; Department of Biostatistics, School of Public Health, Peking University, Beijing, China (X.Z.).
  • Cao R; Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China (X.L., S.W., G.Z., Y.G.).
  • Wang X; Department of Cardiology, People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, China (S.X.).
  • Hua Q; Department of Cardiology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China (W.W.).
  • Du J; Department of Traditional Chinese Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China (Z.D., R.C.).
  • Fan J; Department of Cardiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China (X.W.).
  • Mao J; Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, China (Qi Hua).
  • Jiang W; Department of Cardiology of Integrated Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China (J.D.).
  • Yuan H; Department of Cardiology, Yantaishan Hospital, Yantai, China (J.F.).
  • Chen Y; Department of Cardiology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China (J.M.).
  • Xu Y; Institute for Brain Disorders, Beijing University of Chinese Medicine, Beijing, China (X.L., Y.G.).
  • Li Z; Department of Cardiology, Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China (W.J.).
  • Zhang J; Department of Cardiology, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China (H.Y.).
  • Dong G; Department of Cardiology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China (Y.C.).
  • Zhen H; Department of Cardiovascular Medicine, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China (Y.X.).
  • Ding R; Department of Cardiology, People's Hospital of Liaoning Province, Shenyang, China (Z.L.).
  • Wu Z; Department of Cardiology, Chengdu First People's Hospital, Chengdu, China (J.Z.).
  • Gao Y; Department of Hypertension, Jinan Hospital of Traditional Chinese Medicine, Jinan, China (Guiying Dong).
Circ Cardiovasc Qual Outcomes ; 15(3): e007923, 2022 03.
Article em En | MEDLINE | ID: mdl-35105177

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Hipertensão Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Hipertensão Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article